Paper412502
Thymidine concentrations in serum and urine of different animal species and man.
Nottebrock H and 1 other. Biochem Pharmacol, 1977. Cited by 122 papers, by iCite.
Cite this record
ConductScience Library. Thymidine concentrations in serum and urine of different animal species and man. Papers, record 412502. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/412502
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Thymidine | Major topic |
| Alkaline Phosphatase | |
| Animals | |
| Cats | |
| Cattle | |
| Chickens | |
| DNA | |
| Deer | |
| Dogs | |
| Feces | |
| Goats | |
| Haplorhini | |
| Horses | |
| Humans | |
| Lactobacillus | |
| Macaca mulatta | |
| Mice | |
| Rats | |
| Sheep | |
| Species Specificity | |
| Tissue Distribution |
Source PubMed
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 122 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39688409 | Repurposing zidovudine and 5-fluoro-2'-deoxyuridine as antibiotic drugs made possible by synergy with both trimethoprim and the mitochondrial toxicity-reducing agent uridine. | J Antimicrob Chemother | 2025 | https://conductscience.org/library/papers/39688409 | PubMed |
| 36154614 | Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits. | Antimicrob Agents Chemother | 2022 | https://conductscience.org/library/papers/36154614 | PubMed |
| 35007135 | In Vitro Time-Kill Studies of Trimethoprim/Sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli Using Cation-Adjusted Mueller-Hinton Broth and ISO-Sensitest Broth. | Antimicrob Agents Chemother | 2022 | https://conductscience.org/library/papers/35007135 | PubMed |
| 34480004 | STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [18F]FLT PET imaging. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34480004 | PubMed |
| 33948751 | Revisiting the inoculum effect for Streptococcus pyogenes with a hollow fibre infection model. | Eur J Clin Microbiol Infect Dis | 2021 | https://conductscience.org/library/papers/33948751 | PubMed |
| 33526491 | In Vitro Activity and In Vivo Efficacy of Cefiderocol against Stenotrophomonas maltophilia. | Antimicrob Agents Chemother | 2021 | https://conductscience.org/library/papers/33526491 | PubMed |
| 31591126 | Comparative In Vivo Antibacterial Activity of Human-Simulated Exposures of Cefiderocol and Ceftazidime against Stenotrophomonas maltophilia in the Murine Thigh Model. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/31591126 | PubMed |
| 30483998 | Iclaprim activity against wild-type and corresponding thymidine kinase-deficient Staphylococcus aureus in a mouse protection model. | Eur J Clin Microbiol Infect Dis | 2019 | https://conductscience.org/library/papers/30483998 | PubMed |
| 29378717 | Identification of the In Vivo Pharmacokinetics and Pharmacodynamic Driver of Iclaprim. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29378717 | PubMed |
| 28808156 | Identification of Staphylococcus aureus Factors Required for Pathogenicity and Growth in Human Blood. | Infect Immun | 2017 | https://conductscience.org/library/papers/28808156 | PubMed |
| 27701464 | The Positron Emission Tomography Tracer 3'-Deoxy-3'-[18F]Fluorothymidine ([18F]FLT) Is Not Suitable to Detect Tissue Proliferation Induced by Systemic Yersinia enterocolitica Infection in Mice. | PLoS One | 2016 | https://conductscience.org/library/papers/27701464 | PubMed |
| 27035974 | [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/27035974 | PubMed |
| 24942404 | Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancer. | Invest New Drugs | 2014 | https://conductscience.org/library/papers/24942404 | PubMed |
| 24562648 | Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer. | Eur J Nucl Med Mol Imaging | 2014 | https://conductscience.org/library/papers/24562648 | PubMed |
| 22074768 | Structure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural thymidine analog reporter probe. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22074768 | PubMed |
| 21918023 | Aerococcus urinae and trimethoprim-sulfamethoxazole. | J Clin Microbiol | 2011 | https://conductscience.org/library/papers/21918023 | PubMed |
| 20484820 | PET probes for distinct metabolic pathways have different cell specificities during immune responses in mice. | J Clin Invest | 2010 | https://conductscience.org/library/papers/20484820 | PubMed |
| 20028816 | Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20028816 | PubMed |
| 19564362 | Efficacy of iclaprim against wild-type and thymidine kinase-deficient methicillin-resistant Staphylococcus aureus isolates in an in vitro fibrin clot model. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19564362 | PubMed |
| 19564358 | Tuberculosis and trimethoprim-sulfamethoxazole. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19564358 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/412502
GET https://conductscience.org/api/papers/v1/412502/cited_by?page=2